We are live on ! Find out more
BSX icon

Boston Scientific

1,512 hedge funds and large institutions have $120B invested in Boston Scientific in 2024 Q4 according to their latest regulatory filings, with 218 funds opening new positions, 617 increasing their positions, 489 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 218 | Existing positions closed: 83

26% more repeat investments, than reductions

Existing positions increased: 617 | Existing positions reduced: 489

9% more capital invested

Capital invested by funds: $111B → $120B (+$9.45B)

8% more funds holding

Funds holding: 1,3951,512 (+117)

8% more funds holding in top 10

Funds holding in top 10: 3639 (+3)

1.08% more ownership

Funds ownership: 89.89%90.98% (+1.1%)

13% less call options, than puts

Call options by funds: $797M | Put options by funds: $912M

Holders
1,512
Holders Change
+117
Holders Change %
+8.39%
% of All Funds
19.92%
Holding in Top 10
39
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+8.33%
% of All Funds
0.51%
New
218
Increased
617
Reduced
489
Closed
83
Calls
$797M
Puts
$912M
Net Calls
-$115M
Net Calls Change
+$168M
Name Holding Trade Value Shares
Change
Change in
Stake
HCA
501
Harbor Capital Advisors
Illinois
$4.2M +$101K +1,153 +3%
MGM
502
Miura Global Management
New York
$4.2M -$2.91M -33,000 -41%
NSEDCP
503
NJ State Employees Deferred Compensation Plan
New Jersey
$4.2M -$704K -8,000 -15%
NMIMC
504
Northwestern Mutual Investment Management Company
Wisconsin
$4.18M +$10.7K +122 +0.3%
MPPLM
505
Midwest Professional Planners Ltd (MPPL)
Wisconsin
$4.16M -$93.9K -1,067 -2%
ASN
506
Advisory Services Network
Georgia
$4.12M -$318K -3,616 -7%
BIP
507
Bouvel Investment Partners
Pennsylvania
$4.1M +$66.8K +759 +2%
FHB
508
First Hawaiian Bank
Hawaii
$4.1M -$760K -8,638 -16%
AI
509
Atria Investments
North Carolina
$3.98M -$53.2K -604 -1%
TMAM
510
Tokio Marine Asset Management
Japan
$3.95M +$207K +2,348 +6%
AC
511
Allstate Corporation
Illinois
$3.91M +$3.85M +43,744 New
NW
512
NewEdge Wealth
Pennsylvania
$3.89M -$47.5K -540 -1%
CGIM
513
Capital Group Investment Management
Singapore
$3.84M +$1.81M +20,523 +91%
VAS
514
Vestmark Advisory Solutions
Massachusetts
$3.84M -$78.7K -894 -2%
SCM
515
Silvant Capital Management
Georgia
$3.82M
UCFA
516
United Capital Financial Advisors
Texas
$3.75M -$46.5K -528 -1%
VI
517
Vestcor Inc
New Brunswick, Canada
$3.72M +$116K +1,313 +3%
BG
518
BDF Gestion
France
$3.66M -$469K -5,329 -11%
TPM
519
Triasima Portfolio Management
Quebec, Canada
$3.66M +$951K +10,800 +36%
UB
520
UMB Bank
Missouri
$3.64M +$145K +1,650 +4%
OHIS
521
Oak Harvest Investment Services
Texas
$3.64M +$2.6M +29,526 +262%
GJWM
522
Gilliland Jeter Wealth Management
Arkansas
$3.62M -$81.1K -921 -2%
EAM
523
Exome Asset Management
New York
$3.62M +$3.57M +40,500 New
GVAG
524
Great Valley Advisor Group
Delaware
$3.59M -$25.7K -292 -0.7%
LRWA
525
Long Run Wealth Advisors
New York
$3.55M -$319K -3,624 -8%

BSX Hedge Fund Activity: Q4 2024 in Review

1,512 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2024, worth a combined $120B — up 8.5% from $111B a quarter earlier.

Buyers outnumbered sellers: 218 funds opened new BSX positions and 83 closed out — a net gain of 135 holders — while 617 added to existing stakes and 489 trimmed.

The largest buyer was BlackRock, adding an estimated $909M. The largest seller was Massachusetts Financial Services, cutting an estimated $529M.

  • 1,512 institutional investors held Boston Scientific (BSX) as of Q4 2024, up from 1,395 in Q3 2024.
  • Funds reported $120B of Boston Scientific stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 218 funds opened new Boston Scientific positions in Q4 2024 and 83 closed out, a net change of +135 holders.
  • The largest Boston Scientific buyer in Q4 2024 was BlackRock, an estimated $909M added.
  • The largest Boston Scientific seller in Q4 2024 was Massachusetts Financial Services, an estimated $529M sold.

Based on aggregated 13F filings for Q4 2024.